Veracyte | VCYT - 流动负债



金融业
股票价格
USD 24.16
资产
USD 1.57B
现金及等价物
USD 199.83M
销售成本
USD 45.07M
流动资产
USD 467.88M
流动负债
USD 84.21M
债务
USD 40.11M
EBIT
USD 18.02M
EBITDA
USD 41.24M
员工
824
EPS每股收益
USD 0.51
股本和储备
USD 1.43B
销售毛利
USD 107.1M
债务利息支出
USD 2K
利息收入
USD 3.88M
贷款资金
USD 0
市值
USD 1.85B
净收入
USD 31.5M
营业费用
USD 133.73M
营业利润
USD 18.02M
普通股股本
USD 80.39M
PE价格收益
29.55
税前利润
USD 21.12M
销售收入
USD 151.75M
销售和管理费用
USD 57.95M
股票
USD 25.82M
贸易债权人
USD 9.71M
应收帐款人
USD 56.79M


流动负债 更改 日
Agenus USD 231.82M 17.42M 2026-06
Agilent USD 2.29B 20M 2026-06
Anika Therapeutics USD 22.15M 1.18M 2026-06
Arrowhead Research USD 283.35M 11.87M 2026-06
Bruker USD 1.17B 32.6M 2026-09
Heron Therapeutics USD 92.14M 1.63M 2026-06
Illumina USD 1.16B 422M 2026-09
Intrexon USD 23.02M 38K 2024-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Laboratory Of America USD 2.82B 695M 2026-09
Ligand Pharmaceuticals USD 500.57M 453.83M 2026-09
Myriad Genetics USD 130.7M 500K 2026-06
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Roche Holding CHF 28.85B 846M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Siemens EUR 45.11B 4.4B 2026-06
Sonic Healthcare AUD 2.23B 92.84M 2024-12
Thermo Fisher Scientific USD 14.17B 899M 2026-09
Veracyte USD 84.21M 21.47M 2026-09
Waters USD 2.4B 126M 2026-06